By Nicola Klein, MD, PhD, Director, Kaiser Permanente Vaccine Study Center As a research scientist for the Kaiser Permanente Northern California Division of Research and director of KP’s Vaccine Study Center, it’s my job to study the safety and effectiveness…
Among infants of women who received the Tdap pertussis booster vaccine during pregnancy, the risk of contracting pertussis was reduced by an estimated 91 percent during the first two months of life — the critical period before they can receive…
The Kaiser Permanente Vaccine Study Center (VSC), which conducts research to advance scientific understanding of vaccines at all levels of development, published widely-covered studies this fall on both the deficiencies and general safety of two vaccines for children and adolescents.…
